Delivery Order SPE2DB25D3108-SPE2DB25FPCRV
- Not listed
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- On July 30, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,202.16 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in 60-gram units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.57 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM on August 27, 2025, with completion scheduled for August 28, 2025. This competitive award, issued under a firm fixed-price contract with no set-aside designation, represents a single delivery order for a topical pharmaceutical product. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,288.33 delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ZORYVE is a topical dermatological treatment used primarily for inflammatory skin conditions, and this delivery order reflects...
- The Defense Logistics Agency awarded a $23,646.57 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $1,846.66 to supply Zoryve 0.3% Foam in 60-gram quantities. The contract was competitively awarded without set-aside designation and carries a completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.98 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a dermatological pharmaceutical product. The contract, issued on September 12, 2025, with ultimate completion by September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under the...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPCRVDelivery Order
The Defense Logistics Agency awarded a $1,246.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for ZORYVE 0.3% Foam in a 60-gram format, with performance completion targeted for April 22, 2025. This non-set-aside contract was awarded competitively and is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its extensive pharmaceutical and medical supply portfolio. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support Medical contract represents the contractor's capability to fulfill federal medical procurement requirements through open competition and demonstrates the contractor's role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/21/25 |